CERo Therapeutics Holdings, Inc. CERO
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Lawrence Corey | United States | 8529316 | 0 | 8529316 | 0 | 8529316 | 5.7 % | 13/12/2024 |
| SMS Revocable Trust | U.S.A. | 996669 | 0 | 996669 | 0 | 996669 | 6.7 % | 20/11/2024 |
| Stuart Sloan | U.S.A. | 996669 | 0 | 996669 | 0 | 996669 | 6.7 % | 20/11/2024 |
| YK Bioventures Opportunities GP I, LLC (F/K/A YK Bioventures, LLC) | Delaware | 0 | 22620783 | 0 | 0 | 22620783 | 15 % | 14/11/2024 |
| Gary Yeung | Delaware | 0 | 22620783 | 0 | 0 | 22620783 | 15 % | 14/11/2024 |
| Mitchell Kossar | Delaware | 0 | 22620783 | 0 | 0 | 22620783 | 15 % | 14/11/2024 |
| LLC) | Delaware | 0 | 22620783 | 0 | 0 | 22620783 | 15 % | 14/11/2024 |
| Brian G. Atwood | 125000 | 19607313 | 125000 | 19607313 | 19732313 | 13.4 % | 30/10/2024 | |
| Lynne H. Edminster | 0 | 19607313 | 0 | 19607313 | 19607313 | 13.3 % | 30/10/2024 | |
| Trust dtd 4-2-2000 | 0 | 19607313 | 0 | 19607313 | 19607313 | 13.3 % | 30/10/2024 |